Connect with us

Hi, what are you looking for?

Capital Business
Capital Business
A malaria patient rests at a hospital in South Sudan run by Italian NGO CCM/AFP

World

Novartis to inject $100 mn into malaria drug research

A malaria patient rests at a hospital in South Sudan run by Italian NGO CCM/AFP

ZURICH, Switzerland, Apr 17 – Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016.

There were some 216 million cases of malaria worldwide in 2016, an increase of five million from the year before, according to the World Health Organization.

Around 90 percent of the 445,000 of malaria-related deaths occurred in Africa, but people in southeast Asia, the eastern Mediterranean, the western Pacific and the Americas are also considered at risk.

In a bid to redress the disproportionate burden carried by African countries, Novartis said it would establish a strategy aimed at ensuring equitable pricing.

In a statement, the company also said it would “further help expand access” to treatment for children with malaria.

Novartis’s announcement came as Senegal hosted a pan-African conference this week on the fight against malaria.

Deaths from malaria dropped by over 60 percent from 2000 to 2015, but because of growing resistance to available treatments and insecticides, there is a risk that the progress made so far may be slowed.

“Resistance to treatment presents the biggest threat to the incredible progress that has been made in the fight against malaria in the past 20 years,” Novartis CEO Vas Narasimhan said.

“We cannot afford to wait; this is why we are committing to advance the research and development of next-generation treatments,” he added.

Advertisement. Scroll to continue reading.
Click to comment
Advertisement

More on Capital Business

Executive Lifestyle

NAIROBI, Kenya, Mar 12 – The country’s super wealthy individuals are increasing their holding of bonds, gold and cash, a new report by Knight...

Ask Kirubi

NAIROBI, Kenya, Mar 9 – Businessman and industrialist Dr. Chris Kirubi has urged members of the public to exercise extreme caution when making any...

Headlines

NAIROBI, Kenya, Mar 18 – Commercial Banks have been ordered to provide relief to borrowers on their personal loans, with loans eligible from March...

Ask Kirubi

NAIROBI, Kenya, Mar 24 – Businessman and industrialist Dr. Chris Kirubi is set to own half of Centum Investment Company PLC, following a go-ahead...

Kenya

NAIROBI, Kenya, Jun17 – Kenya’s tea leaves manufacturer Kericho Gold, has been awarded the Superbrands Seal by Superbrands East Africa for their quality variety...

Coronavirus

NAIROBI, Kenya, Mar 22 – Airtel Kenya is offering free internet access for students in order to enable continued learning at home in the...

Coronavirus

NAIROBI, Kenya, Apr 13 – As the local telecommunications industry gears up to roll out 5G networks in the country, the Communications Authority of...

Headlines

NAIROBI, Kenya, Mar 16 – The World Bank has given the Kenyan government USD 60 Million (Sh6.1 billion) to help combat the deadly coronavirus pandemic...